Troy Edward Wilson

Companies

• Atrium Therapeutics, Inc.Board member Feb 26, 2026 to now¹
• Avidity Biosciences, Inc.Board member Jun 11, 2020 to now²
• Kura OncologyBoard member Mar 16, 2015 to now³
• Kura OncologyChief executive officer Mar 16, 2015 to now³
• Kura OncologyPresident Mar 16, 2015 to now³
• Puma BiotechnologyBoard member Oct 21, 2013 to now⁴
• Zosano Pharma CorpBoard member Jan 26, 2015 to Jul 18, 2019⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• KOKura Oncology KURA735,456 shares⁶$6.8M at $9.21Aug 24, 2026
• PBPuma Biotechnology PBYI54,900 shares⁷$586.3K at $10.68Sep 16, 2026
• ATAtrium Therapeutics, Inc. RNA11,731 shares⁸$90.6K at $7.72Feb 26, 2026
• ABAvidity Biosciences, Inc.0 shares⁹Feb 27, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Sep 14, 2026Sold 5,000 shares at $9.10 of Puma Biotechnology⁷
• Aug 24, 2026Bought 100,000 shares at $12.39 of Kura Oncology⁶
• Aug 17, 2026Bought 100,000 shares at $11.12 of Kura Oncology¹⁰
• Jun 12, 2026Sold 10,800 shares at $7.20 of Puma Biotechnology¹¹
• Jun 11, 2026Granted 27,000 shares of Puma Biotechnology¹¹
• Mar 23, 2026Exercised options 6,103 shares at $6.15 of Kura Oncology¹²
• Feb 27, 2026Returned to company 13,711 shares of Avidity Biosciences, Inc.⁹
• Feb 27, 2026Returned to company 65,091 shares of Avidity Biosciences, Inc.⁹
• Nov 13, 2025Granted 182,500 shares of Kura Oncology¹³
• Sep 29, 2025Sold 36,615 shares at $8.94 of Kura Oncology¹⁴
• Sep 27, 2025Granted 182,500 shares of Kura Oncology¹⁴
• Sep 8, 2025Bought 50,000 shares at $8.20 of Kura Oncology¹⁵
• Sep 5, 2025Sold 15,000 shares at $50.00 of Avidity Biosciences, Inc.¹⁶
• Sep 5, 2025Sold 14,500 shares at $50.00 of Avidity Biosciences, Inc.¹⁶
• Sep 5, 2025Exercised options 14,500 shares at $12.48 of Avidity Biosciences, Inc.¹⁶
• Aug 13, 2025Bought 13,494 shares at $6.64 of Kura Oncology¹⁷
• Aug 12, 2025Bought 36,506 shares at $5.85 of Kura Oncology¹⁷
• Aug 6, 2025Sold 17,777 shares at $45.00 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Sold 17,777 shares at $45.00 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Sold 15,000 shares at $45.00 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Sold 15,000 shares at $45.00 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Sold 7,500 shares at $45.00 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Exercised options 7,500 shares at $12.48 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Sold 22,000 shares at $45.00 of Avidity Biosciences, Inc.¹⁸
• Aug 6, 2025Exercised options 22,000 shares at $12.03 of Avidity Biosciences, Inc.¹⁸